Sanofi: Q1 Earnings Reflect Growth And Strategic Acquisitions (Rating Upgrade) [Seeking Alpha]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Seeking Alpha
Key drugs like Nexviazyme and Altuviiio showed strong performance, with the former doubling its revenue. Despite a high profitability margin, Sanofi's growth lags the sector, with a concerning -15.25% Y/Y EBITDA growth. Investment recommendation: Buy Sanofi due to its moderate risk and potential upside, but maintain portfolio diversification. Sanofi's Q1 Financial Results and Drug Portfolio Expansion I last wrote on Sanofi NASDAQ: SNY OTCPK:SNYNF ) after it acquired Inhibrx for $2.2 billion earlier this year. The deal centered around INBRX-101, a drug targeting the rare disease Recommended For You Recommended For You About SNY Stock Related Stocks Trending Analysis Trending News
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- Sanofi (SNY) Signs Deal for AI-Powered Drug Development [Yahoo! Finance]Yahoo! Finance
- ChatGPT Parent Open AI Partners With Sanofi, Formation Bio To Boost AI-Driven Drug Development [Yahoo! Finance]Yahoo! Finance
- TransPerfect Announces GlobalLink NEXT Americas 2024 Conference in New York [Yahoo! Finance]Yahoo! Finance
- Icy Hot Named the Official Topical Pain Relief Partner of Tough Mudder U.S. & Canada [Yahoo! Finance]Yahoo! Finance
- Exploring Euronext Paris Dividend Stocks In May 2024 [Yahoo! Finance]Yahoo! Finance
SNY
Sec Filings
- 5/2/24 - Form 6-K
- 4/25/24 - Form 6-K
- 4/4/24 - Form F-3ASR
- SNY's page on the SEC website